These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 89451)

  • 1. Thymidine sensitivity of cultured leukaemic lymphocytes.
    Fox RM; Piddington SK; Tripp EH; Dudman NP; Tattersall MH
    Lancet; 1979 Aug; 2(8139):391-3. PubMed ID: 89451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential metabolism of thymidine in human lymphoid and melanoma cells in vitro.
    Leyva A; Appel H; Kraal I; Pinedo HM
    Anticancer Res; 1984; 4(3):173-8. PubMed ID: 6087718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for the differential sensitivity of B and T lymphocytes to growth inhibition by thymidine and 5-fluorouracil.
    el-Assouli SM
    Leuk Res; 1985; 9(3):391-8. PubMed ID: 3873586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse deoxyribonucleotide profiles in cultured human cells with differential sensitivity to thymidine.
    Leyva A; Appel H; Pinedo HM
    Cancer Biochem Biophys; 1984 Sep; 7(3):231-7. PubMed ID: 6333268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of leukemic human null lymphocytes to deoxynucleosides.
    Fox RM; Tripp EH; Piddington SK; Tattersall MH
    Cancer Res; 1980 Sep; 40(9):3383-6. PubMed ID: 6253063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecto-adenosine triphosphatase deficiency in cultured human T and null leukemic lymphocytes. A biochemical basis for thymidine sensitivity.
    Fox RM; Piddington SK; Tripp EH; Tattersall MH
    J Clin Invest; 1981 Aug; 68(2):544-52. PubMed ID: 6114965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine.
    Fox RM; Kefford RF; Tripp EH; Taylor IW
    Cancer Res; 1981 Dec; 41(12 Pt 1):5141-50. PubMed ID: 6272990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of B-cell mitogen-induced and spontaneous thymidine uptake in vitro in chronic B-lymphocytic leukaemia cells.
    Juliusson G; Robèrt KH; Nilsson B; Gahrton G
    Br J Haematol; 1985 Jul; 60(3):429-36. PubMed ID: 2410008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Electrophoretic mobility in acute null cell lymphoblastic leukemia].
    Pavone V; Jirillo E; Specchia G; Loria MP; Liso V
    Boll Ist Sieroter Milan; 1982; 61(3):225-9. PubMed ID: 6985423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood.
    Shaw T; Smillie RH; MacPhee DG
    Mutat Res; 1988; 200(1-2):99-116. PubMed ID: 3393166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical basis for the differential sensitivity of human T- and B-lymphocyte lines to 5-fluorouracil.
    Piper AA; Fox RM
    Cancer Res; 1982 Sep; 42(9):3753-60. PubMed ID: 6179610
    [No Abstract]   [Full Text] [Related]  

  • 12. Comments on "The molecular basis for the differential sensitivity of B and T lymphocytes to growth inhibition by thymidine and 5-fluorouracil".
    Srivastava BI
    Leuk Res; 1988; 12(8):699. PubMed ID: 3263551
    [No Abstract]   [Full Text] [Related]  

  • 13. Total and surface-located sialic acid levels in normal and leukaemic lymphocytes: relationship to T and B cell nature and to location in vivo.
    O'Kennedy R; Smyth H; Corrigan A; Clyness M
    Eur J Cancer Clin Oncol; 1982 May; 18(5):437-46. PubMed ID: 6981512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochemical profile of B and T leukaemic lymphocytes with special reference to acute lymphoblastic leukaemia.
    Catovsky D; Galetto J; Okos A; Miliani E; Galton DA
    J Clin Pathol; 1974 Oct; 27(10):767-71. PubMed ID: 4547770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes.
    Farber CM; Liebes LF; Kanganis DN; Silber R
    J Immunol; 1984 May; 132(5):2543-6. PubMed ID: 6609202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymidine as a chemotherapeutic agent: pharmacologic, cytokinetic, and biochemical studies in a patient with T-cell acute lymphocytic leukemia.
    Howell SB; Chu B; Mendelsohn J; Carson DA; Kung FH; Seegmiller JE
    J Natl Cancer Inst; 1980 Aug; 65(2):277-84. PubMed ID: 6967527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulating capacity of blast cells from patients with chronic myelocytic leukaemia, in blastic crisis in 'one-way' mixed lymphoycte reaction: lack of evidence for T lymphoblastic conversion.
    Han T; Gomez GA; Minowada J
    Immunology; 1978 Aug; 35(2):299-305. PubMed ID: 155646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte cholesterol synthesis in chronic lymphocytic leukemia.
    Sanghvi A; Warty V
    Life Sci; 1982 Aug; 31(9):893-8. PubMed ID: 6983639
    [No Abstract]   [Full Text] [Related]  

  • 19. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in DNA and purine nucleotide synthesis in lymphoid cells and sensitivity to glucocorticoids associated with the impairment of differentiation and immune function in mice during tumor growth. Spleen T- and B-lymphocytes].
    Khramtsova SN; Potapova GI; Dmitrieva LV; Shapot VS
    Biokhimiia; 1986 Apr; 51(4):635-43. PubMed ID: 3085734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.